Moreover, treatment with cytokines such as interferon-alpha (IFN- ɑ) (used in treatments for cancer and chronic hepatitis C) can result in an increased risk of depression, with studies suggesting a prevalence of 20%–30% (Sockalingam et al., 2011). This evidence concerns the gene IFNA1 and depressive disorder.